Study Title
Phase II Study of Neoadjuvant Lu-177-PSMA-617 in Patients With High Risk Localized Prostate Cancer Undergoing Radical Prostatectomy
Study Details
Description:
Male adults with a confirmed diagnosis of prostate adenocarcinoma who meet criteria for localized high risk prostate cancer according to the NCCN guidelines and who are eligible for prostatectomy will be invited to participate. Criteria for high-risk prostate cancer include patients with preoperative prostate biopsy score of Gleason 8 (GS8) (Grade group 4 [GG4]) or higher. Patients also need to have a positive PSMA scan on 68-Ga-PSMA-11 PET/CT scan.
Sponsor:
Hackensack Meridian Health
Contacts:
Oncology Clinical Research Referral Officeoncologyresearchreferral@hmhn.org
551-996-1777
Government Study Link:
NCT06798558 - Click here to see study onClinicalTrials.gov
Drug Details